Related Experiment Video
Updated: Jun 15, 2026
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
Characterization and classification of adverse drug interactions
Masataka Takarabe1, Daichi Shigemizu, Masaaki Kotera
1Bioinformatics Center, Institute for Chemical Research, Kyoto University, Uji, Kyoto 611-0011, Japan. takarabe@kuicr.kyoto-u.ac.jp
Summary
Analyzing drug interactions using the Anatomical Therapeutic Chemical (ATC) classification reveals key drug properties linked to interaction mechanisms and symptoms, aiding safer drug development.
Area of Science:
- Pharmacology
- Drug Discovery
- Computational Chemistry
Background:
- Drug interactions pose significant health risks and impact new drug development.
- Previous research established a drug interaction network from Japanese drug package inserts.
- This network highlighted shared drug targets and metabolizing enzymes in interactions.
Purpose of the Study:
- To analyze the drug interaction network by categorizing drugs using the Anatomical Therapeutic Chemical (ATC) classification.
- To identify drug properties associated with interaction mechanisms and symptoms.
- To investigate relationships between drug groups and their interaction profiles.
Main Methods:
- Extraction of drug interaction data from Japanese drug package inserts.
- Construction of a comprehensive drug interaction network.
- Merging of drugs into categories based on the Anatomical Therapeutic Chemical (ATC) classification.
- Analysis of merged data to identify drug properties related to interaction mechanisms and symptoms.
Main Results:
- The merged drug interaction data revealed distinct drug properties.
- These properties were associated with specific drug interaction mechanisms and clinical symptoms.
- Relationships between drug categories and their interaction mechanisms/symptoms were elucidated.
Conclusions:
- Categorizing drugs via the ATC system provides insights into drug interaction mechanisms and symptoms.
- This approach aids in understanding drug properties relevant to adverse events.
- The findings contribute to safer drug development and improved patient health outcomes.
Related Concept Videos
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:00Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:30Combined Effects of Drugs: Antagonism
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
01:14Agonism and Antagonism: Quantification
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...